Trials / Completed
CompletedNCT01789775
Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 114 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Phase 3 efficacy and safety study of CD07805/47 topical gel in subjects with facial erythema associated with rosacea. The study hypothesis is that CD07805/47 gel, applied topically once daily is more efficacious than vehicle and provides an acceptable safety profile in the treatment of facial erythema associated with rosacea
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Drug: CD07805/47 gel | |
| DRUG | CD07805/47 gel Placebo |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2013-02-12
- Last updated
- 2014-10-20
- Results posted
- 2014-10-20
Locations
7 sites across 3 countries: France, Russia, Sweden
Source: ClinicalTrials.gov record NCT01789775. Inclusion in this directory is not an endorsement.